Cardiotropic formulation

Details Cardiotropic formulation Cardiotropic formulation

1995-06-28

1997-02-11

Spivack, Phyllis G.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

514 6, 514 45, 514 46, 5142258, 514651, A61K 31135, A61K 3154, A61K 31705, A61K 3816

Patent

active

056021054

ABSTRACT:
The invention provides a cardiotropic formulation comprising a cardiac glycoside, a beta-adrenergic receptor stimulant nicotinamide adenine dinucleotide, cytochrome C and inosine for use in conditions of heart failure.

REFERENCES:
Kostin, V. I. (Dep. Pharmacol., Med. Inst., Kemerovo 650029, USSR). Farmakol. Toksikol. (Moscow), 52(6), 49-52 (Russ) 1989.
Karsanov et al. (Repub. Res. Cent. Med. Biophys., Tbilisi, USSR), Izv. Akad. Nauk Gruz. SSR, Ser. Biol., 8(6), 393-9 (Russ) 1982.

Affiliated with

Also associated with

Rating

Cardiotropic formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cardiotropic formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cardiotropic formulation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-342052